The activities of three sulphonamides and trimethoprim against strains of Pseudomonas aeruginosa have been studied. Sulphadiazine had most activity, sulphadimidine had little, and the activity of sulphamethoxazole was intermediate. According to their sensitivity to sulphamethoxazole, strains were divided into two groups: “highly resistant” (16%, MIC>1000 μg per ml) and “moderately resistant” (84%, MIC≤ 1000 μg per ml). The former were resistant on disk testing to Sulphatriad 300 μg. Sulphamethoxazole and trimethoprim did not act in synergy against them.
The moderately resistant strains were sensitive to Sulphatriad; trimethoprim and sulphamethoxazole showed marked synergy against them in agar-plate dilution tests. The concentrations of trimethoprim and sulphamethoxazole necessary for synergy lay for each drug within the range of concentrations at which they have been found in urine, and the ratio of their MICs when acting in synergy was similar to the ratio of their concentrations in urine.
It is suggested that a disk containing trimethoprim and sulphamethoxazole in a ratio of 1:2 rather than 1:20 would be more appropriate when testing strains from urine for their sensitivity to co-trimoxazole.
BrumfittW.,
PursellR.1972; Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole and trimethoprim in treatment of urinary infection. Br. med. J 2:673
BushbyS. R. M.,
BarnettM.1967; Trimethoprim-sulphonamides: in vitro sensitivity of 384 strains of bacteria. In Proc. 5th int. Congr. Chemother. (Vienna 1967), Abst Al-6/11:753
Van CampK.1970; Etude clinique comparative d’un nouvel agent chimiotherapique dans les infections aigues des voies urinaires. Proc. 5th int. Congr. infect. Dis 6:31
ElionG. B.,
SingerS.,
HitchingsG. H.1954; Antagonists of nucleic acid derivatives, VIII. Synergism in combinations of biochemically related antimetabolites. J. biol. Chem 208:477
HofstetterA.1970; Erfahungen mit dem Breitband Chemotherapeutikum Eusaprim bei entziindlichen Erkrangungen des Urogenitaltraktes. Wehrmed. Mschr 14:114
KaplanS. A.,
WeinfeldR. E.,
AbruzzoC. W.,
McFadenK.,
Lewis JackM.,
WeissmanL.1973; Pharmacokinetic profile of trimethoprim-sulphamethoxazole in man. J. infect. Dis 128: Suppl S547
KerryD. W.,
Hamilton-MillerJ. M. T.,
BrumfittW.1975; Trimethoprim and rifampicin: in vitro activities separately and in combination. J. Antimicrob. Chemother 1:417